306 related articles for article (PubMed ID: 7558949)
41. Surgical results of large and giant pituitary adenomas with special consideration of ophthalmologic outcomes.
Müslüman AM; Cansever T; Yılmaz A; Kanat A; Oba E; Çavuşoğlu H; Sirinoğlu D; Aydın Y
World Neurosurg; 2011; 76(1-2):141-8; discussion 63-6. PubMed ID: 21839965
[TBL] [Abstract][Full Text] [Related]
42. The efficacy of conventional radiation therapy in the management of pituitary adenoma.
Sasaki R; Murakami M; Okamoto Y; Kono K; Yoden E; Nakajima T; Nabeshima S; Kuroda Y
Int J Radiat Oncol Biol Phys; 2000 Jul; 47(5):1337-45. PubMed ID: 10889388
[TBL] [Abstract][Full Text] [Related]
43. Progressive improvement of impaired visual acuity during the first year after transsphenoidal surgery for non-functioning pituitary macroadenoma.
Dekkers OM; de Keizer RJ; Roelfsema F; Vd Klaauw AA; Honkoop PJ; van Dulken H; Smit JW; Romijn JA; Pereira AM
Pituitary; 2007; 10(1):61-5. PubMed ID: 17318437
[TBL] [Abstract][Full Text] [Related]
44. Is it possible to avoid hypopituitarism after irradiation of pituitary adenomas by the Leksell gamma knife?
Marek J; Jezková J; Hána V; Krsek M; Bandúrová L; Pecen L; Vladyka V; Liscák R
Eur J Endocrinol; 2011 Feb; 164(2):169-78. PubMed ID: 21071488
[TBL] [Abstract][Full Text] [Related]
45. Visual complications following irradiation for pituitary adenomas and craniopharyngiomas.
Harris JR; Levene MB
Radiology; 1976 Jul; 120(1):167-71. PubMed ID: 935443
[TBL] [Abstract][Full Text] [Related]
46. Long-term results of radiotherapy in the treatment of pituitary adenomas in children and adolescents.
Grigsby PW; Thomas PR; Simpson JR; Fineberg BB
Am J Clin Oncol; 1988 Dec; 11(6):607-11. PubMed ID: 3189225
[TBL] [Abstract][Full Text] [Related]
47. Fractionated stereotactic radiotherapy for pituitary adenomas following microsurgical resection: safety and efficacy.
McClelland S; Higgins PD; Gerbi BJ; Orner JB; Hall WA
Technol Cancer Res Treat; 2007 Jun; 6(3):177-80. PubMed ID: 17535025
[TBL] [Abstract][Full Text] [Related]
48. Radiotherapy for pituitary adenoma: long-term outcome and sequelae.
McCord MW; Buatti JM; Fennell EM; Mendenhall WM; Marcus RB; Rhoton AL; Grant MB; Friedman WA
Int J Radiat Oncol Biol Phys; 1997 Sep; 39(2):437-44. PubMed ID: 9308948
[TBL] [Abstract][Full Text] [Related]
49. Role of radiation therapy in clinical hormonally-active pituitary adenomas.
Tsang RW; Brierley JD; Panzarella T; Gospodarowicz MK; Sutcliffe SB; Simpson WJ
Radiother Oncol; 1996 Oct; 41(1):45-53. PubMed ID: 8961367
[TBL] [Abstract][Full Text] [Related]
50. Preliminary visual field preservation after staged CyberKnife radiosurgery for perioptic lesions.
Pham CJ; Chang SD; Gibbs IC; Jones P; Heilbrun MP; Adler JR
Neurosurgery; 2004 Apr; 54(4):799-810; discussion 810-2. PubMed ID: 15046645
[TBL] [Abstract][Full Text] [Related]
51. Outcome of partially irradiated recurrent nonfunctioning pituitary macroadenoma by gamma knife radiosurgery.
Shen CC; You WC; Sun MH; Lee SD; Tsou HK; Chen YJ; Sheu ML; Sheehan J; Pan HC
J Neurooncol; 2018 Sep; 139(3):767-775. PubMed ID: 29948768
[TBL] [Abstract][Full Text] [Related]
52. Postoperative radiation therapy for pituitary adenoma.
Isobe K; Ohta M; Yasuda' S; Uno T; Hara R; Machida N; Saeki N; Yamaura A; Shigematsu N; Ito H
J Neurooncol; 2000 Jun; 48(2):135-40. PubMed ID: 11083077
[TBL] [Abstract][Full Text] [Related]
53. The role of visual fields and visual acuity in the treatment of chromophobe adenoma of the pituitary gland. A case report.
Frankelson EN
Can J Ophthalmol; 1974 Oct; 9(4):453-7. PubMed ID: 4423942
[No Abstract] [Full Text] [Related]
54. [A case of radiation optic neuropathy after resection of a pituitary adenoma].
Yoshii M; Okisaka S; Yanagawa Y; Takiguchi H
Nippon Ganka Gakkai Zasshi; 1995 Jun; 99(6):739-44. PubMed ID: 7611012
[TBL] [Abstract][Full Text] [Related]
55. Visual outcome of surgically managed pituitary adenomas followed-up at the Yaoundé Central Hospital.
Njami VA; Epee E; Nguifo Fongang EJ; Bello F; Ekoumelon R; Bukam ED; Sobngwi E; Djientcheu VP
Br J Neurosurg; 2018 Oct; 32(5):521-527. PubMed ID: 30073855
[TBL] [Abstract][Full Text] [Related]
56. Gamma surgery in the treatment of nonsecretory pituitary macroadenoma.
Mingione V; Yen CP; Vance ML; Steiner M; Sheehan J; Laws ER; Steiner L
J Neurosurg; 2006 Jun; 104(6):876-83. PubMed ID: 16776330
[TBL] [Abstract][Full Text] [Related]
57. Meningioma causing visual impairment: outcomes and toxicity after intensity modulated radiation therapy.
Maclean J; Fersht N; Bremner F; Stacey C; Sivabalasingham S; Short S
Int J Radiat Oncol Biol Phys; 2013 Mar; 85(4):e179-86. PubMed ID: 23245285
[TBL] [Abstract][Full Text] [Related]
58. Treatment of pituitary adenomas using radiosurgery and radiotherapy: a single center experience and review of literature.
Sun DQ; Cheng JJ; Frazier JL; Batra S; Wand G; Kleinberg LR; Rigamonti D; Quinones-Hinojosa A; Salvatori R; Lim M
Neurosurg Rev; 2010 Apr; 34(2):181-9. PubMed ID: 20838838
[TBL] [Abstract][Full Text] [Related]
59. Long-term follow-up of radiotherapy for pituitary adenoma: the absence of late recurrence after greater than or equal to 4500 cGy.
McCollough WM; Marcus RB; Rhoton AL; Ballinger WE; Million RR
Int J Radiat Oncol Biol Phys; 1991 Aug; 21(3):607-14. PubMed ID: 1907958
[TBL] [Abstract][Full Text] [Related]
60. Neuro-ophthalmological assessment of vision before and after radiation therapy alone for pituitary macroadenomas.
Rush SC; Kupersmith MJ; Lerch I; Cooper P; Ransohoff J; Newall J
J Neurosurg; 1990 Apr; 72(4):594-9. PubMed ID: 2319319
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
